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Abstract	
Background	
PET-MR	 scanners	 are	 beginning	 to	 be	 employed	 for	 quantitative	 myocardial	
perfusion	 imaging.	 In	 order	 to	 examine	 simultaneous	 perfusion	 calculations,	 this	
work	 describes	 a	 feasibility	 study	 of	 simultaneous	 PET-MR	 of	 gadolinium-based	
contrast	agent	(GBCA)	and	PET	radiotracer	in	a	novel	cardiac	perfusion	phantom.		
Results	
[18F]F-	and	GBCA	were	injected	simultaneously	into	a	cardiac	phantom	using	a	range	
of	ground-truth	myocardial	perfusion	rates	of	1	to	5	ml/g/min.	PET	quantification	of	
K1	 (ml/g/min)	 was	 performed	 using	 a	 single	 tissue	 compartment	 model.	 MR	
perfusion	 was	 calculated	 using	 a	 model-independent	 signal	 deconvolution	
technique.	 PET	 and	 MR	 signal	 traces	 from	 the	 phantom	 aorta	 and	 myocardial	
sections	 show	 true	 simultaneous	 PET	 and	 MR	 arterial	 input	 functions	 (AIF)	 and	
myocardial	 uptake	 respectively	 at	 each	 perfusion	 rate.	 Calculation	 of	 perfusion	
parameters	 showed	 both	 K1	 and	 h(t=0)	 (PET	 and	 MR	 perfusion	 parameters	
respectively)	to	be	linearly	related	with	the	ground	truth	perfusion	rate	(PT),	and	also	
linearly	 related	 to	each	other	 (R2=0.99).	 The	highest	difference	 in	perfusion	values	
between	K1	 and	PT	was	 16%	at	 1	ml/g/min,	 and	 the	mean	difference	 for	 all	 other	
perfusion	rates	was	<3%.		
Conclusions	
The	 perfusion	 phantom	 allows	 accurate	 and	 reproducible	 simulation	 of	 the	
myocardial	kinetics	for	simultaneous	PET-MR	imaging,	and	may	find	use	in	protocol	
design	 and	 development	 of	 PET-MR	 based	 quantification	 techniques	 and	 direct	
comparison	of	quantification	of	the	two	modalities.		
Keywords:	PET-MR;	cardiology;	perfusion;	flow	
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Background	
Cardiac	magnetic	 resonance	 (CMR)	plays	an	 increasing	 role	 in	 the	diagnosis	
and	stratification	of	patients	with	suspected	coronary	artery	disease	(CAD)	justified	
by	its	high	spatial	resolution,	tissue	contrast	and	the	ability	to	provide	reproducible	
quantitative	data	on	parameters	such	as	 left	ventricular	volumes	and	mass.	CMR	is	
also	 increasingly	 used	 to	 assess	 inducible	 ischaemia	 (1,	 2).	 In	 carefully	 controlled	
situations,	CMR	techniques	have	been	shown	to	also	provide	absolute	quantitative	
measurements	of	myocardial	blood	 flow	(MBF)	and	myocardial	 flow	reserve	 (MFR)	
(3).		
Positron	 emission	 tomography-computed	 tomography	 (PET)	 imaging	 is	 a	
highly	accurate	method	for	assessment	of	obstructive	coronary	artery	disease	(CAD),	
with	 a	 sensitivity	 and	 specificity	 of	 approximately	 90%	 (4)	 and	 is	 considered	 the	
reference	 method	 for	 non-invasive	 quantification	 of	 myocardial	 perfusion	 (5).		
Dynamic	PET	 imaging	can	be	performed	using	 short-lived	metabolized	 tracers	 (e.g.	
[82Rb]Cl	 ,	 [13N]NH3)	 or	 freely-diffusible	 tracers	 (e.g.	 15O-H2O)	 for	 quantification	 of	
absolute	MBF	and	MFR.	
The	 recent	 introduction	 of	 simultaneous	 hybrid	 PET-MR	 systems	 for	
combined	 molecular	 and	 functional	 imaging	 could	 be	 of	 great	 use	 in	 terms	 of	
understanding	 underlying	 cardiac	 pathophysiology	 and	 improving	 cross-modality	
validation.	Multiple	 images	comprising	structural	and	 functional	 information	of	 the	
same	 tissue	 in	 the	 same	 physiological	 state	 can	 be	 acquired	 simultaneously.	 The	
combination	 of	 PET	 and	 MR	 acquisitions	 can	 provide	 further	 benefits	 in	 cardiac	
imaging	 such	 as	 real-time	 motion	 correction	 (6),	 reduced	 patient	 scan	 time	
compared	to	independent	CMR	and	PET-CT	scans	(7),	and	a	reduction	in	exposure	to	
ionizing	radiation	(8).		
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Due	to	the	demanding	technical	requirements	of	first-pass	perfusion	imaging,	
the	use	of	simultaneous	PET-MR	systems	for	quantitative	cardiac	imaging	is	only	just	
emerging.	Sequential	CMR	and	PET	perfusion	measurements	 in	a	on	 the	same	day	
have	 shown	 that	 physiological	 variations	 in	 the	 time	 between	 studies	 (i.e.	
hemodynamic	 conditions)	 are	 a	 major	 factor	 (9).	 Recent	 work	 has	 performed	
simultaneous	 PET-MR	 in	 [18F]FDG	 cases	 to	 examine	 cardiac	 viability	 (10),	 cardiac	
sarcoma	 (11)	 and	 active	 inflammation	 imaging	 of	 cardiac	 sarcoidosis	 (12).	 MFR	
determined	 from	 [15O]H20	 PET	 from	 both	 PET-MR	 and	 PET-CT	 systems	 has	 been	
compared	from	10	patients,	detailing	a	high	intra-class	correlation	coefficient	of	0.98	
(13).	Another	group	studied	the	feasibility	of	acquiring	MR	and	PET	perfusion	profiles	
simultaneously	 using	 dynamic	 contrast	 enhancement	 MR	 (DCE-MR)	 and	 [13N]NH3	
PET	 for	 10	 patients,	 showing	 a	 correlation	of	 R2=0.67	 for	 rest	 and	 stress	MBF	 and	
R2=0.48	 for	MFR	 (14).	 A	major	 confounding	 factor	 in	 the	 correlation	 between	 PET	
and	 MR	 perfusion	 comparison	 involves	 the	 difference	 in	 the	 tracer	 mechanism.	
Gadolinium	 based	 contrast	 agents	 (GBCA)	 do	 not	 undergo	 any	 intracellular	
processes,	 remaining	 distributed	 only	 within	 the	 extracellular	 space,	 whereas	 PET	
radiotracers	 typically	 enter	 and	 exit	 the	 myocyte.	 Thus	 there	 is	 also	 a	 lack	 of	
similarities	between	approaches	 to	quantify	perfusion	on	CMR	and	PET	techniques	
such	as	modeling	assumptions,	fitting	methods	and	parameter	constraints	(15).	Also	
of	note	in	simultaneous	imaging	is	the	potential	effects	of	contrast	agent	on	the	MR-
based	map	for	attenuation	correction	of	PET	sinograms	(16,	17).	
There	 is	thus	room	to	 improve	correlation	between	PET	and	CMR	perfusion	
quantification	 techniques,	 and	 a	 physiologically	 validated	 phantom	 with	 the	
capability	of	simultaneous	PET-MR	acquisition	is	likely	to	add	to	the	growing	body	of	
knowledge.	Our	 perfusion	 phantom	has	 previously	 been	 validated	 to	 provide	 data	
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suitable	 for	 quantitative	 analysis	 (18)	 and	 has	 been	 employed	 in	MR	 (19)	 and	 CT	
quantification	 (20).	 Our	 work	 here	 follows	 on	 from	 our	 first	 investigations	 of	
simultaneous	 PET-MR	 phantom	 acquisitions	 using	 simultaneous	 injections	 of	
radiotracer	and	GBCA	(21).	We	aimed	to	investigate	if	perfusion	estimates	calculated	
independently	via	PET	and	MR	techniques	are	related.	
	
	
Material	and	Methods	
	
Phantom	
	
We	 used	 an	 in-house	 designed	 and	 built	 myocardial	 perfusion	 phantom,	
which	has	previously	been	described	in	detail	(19).	Briefly,	water	is	pumped	through	
an	MR-safe	myocardial	 perfusion	 phantom	placed	 in	 the	 scanner.	 The	 phantom	 is	
representative	of	the	large	thoracic	vessels	and	of	the	heart	of	a	60	kg	subject.	It	is	
composed	of	 four	 cardiac	 chambers	 (120	ml	 each)	 and	 associated	 thoracic	 vessels	
(aorta,	 pulmonary	 artery,	 pulmonary	 vein,	 vena	 cava).	 A	 schematic	 representation	
detailing	 the	 phantom	 itself	 and	 supporting	 precision	 pumping	 and	 monitoring	
mechanisms	is	shown	in	Figure	1.	Myocardial	perfusion	is	controlled	in	real	time	by	
flow	meters	continuously	sampling	the	flow	rate	by	means	of	high-precision	digital	
flow	meters	(Atrato,	Titan,	Sherborne,	United	Kingdom)	and	providing	re-adjustment	
of	the	speed	of	rotation	of	roller	pumps	through	a	feedback	mechanism.	Perfusion	
values	were	obtained	by	means	of	measurements	of	the	distribution	volume	for	the	
radioactive	 tracer	 and	 for	 the	 GBCA,	 and	 dividing	 the	 flow	 rate	 by	 this	 value.	 All	
pump	 controls	 and	 flow/perfusion	 rates	 are	 handled	 remotely	 from	 a	 custom-
written	 LabVIEW	 application	 (LabVIEW	 Professional	 Development	 System	 2014,	
National	 Instruments,	 Austin	 TX,	 USA)	 running	 on	 dedicated	 workstation	 and	
remotely	 controlled	 using	 an	 iPad	 application	 (Dashboard	 for	 LabVIEW,	 National	
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Instruments,	Austin	TX,	USA).	As	no	radiotracer	or	GBCA	re-entered	the	system	after	
injection,	 we	 utilized	 a	 non-recirculating	 model	 in	 order	 to	 study	 first-pass	
myocardial	perfusion	measurements.		
	
	
Scanning	parameters	
	
We	 performed	 PET-MR	 imaging	 on	 a	 3T	 Siemens	 Biograph	 mMR	 scanner	
(Siemens	Healthcare	GmbH,	 Erlangen,	Germany).	 The	MR	 sequence	 consisted	of	 a	
clinically	 utilized	 imaging	 protocol,	 namely	 a	 2D	 TurboFLASH	 	 saturation	 recovery	
gradient	echo	sequence	(TE=1	ms,	TR=164	ms,	Flip	angle=10o,	slice	thickness=6	mm,	
pixel	spacing=1.875	mm,	matrix	size	144x192	voxels,	with	 temporal	 resolution	of	1	
image	 per	 cardiac	 beat).	 MR	 data	 were	 acquired	 in	 a	 single	 transverse	 plane	
identified	 by	 markings	 on	 the	 phantom,	 the	 locations	 of	 which	 correspond	 to	 a	
known	 dispersion	 volume	 for	 the	 GBCA	 and	 radiotracer.	 Cardiac	 output	 flow	 rate	
was	set	to	3	litres/minute,	with	true	myocardial	perfusion	rates	(hereon	denoted	PT)	
set	to	1,	2,	3,	4	and	5	ml/g/min.	A	previously	validated	dual-bolus	protocol	was	used	
for	 GBCA	 injection,	with	 a	 pre-bolus	 of	 0.001	mmol/kg	 of	 GBCA	 injected	 before	 a	
main	 bolus	 of	 0.01	 mmol/kg	 (22).	 A	 minimum	 pause	 of	 30	 seconds	 was	 allowed	
between	the	pre-bolus	and	the	main	bolus	of	GBCA	to	ensure	return	of	signal	in	the	
vascular	and	myocardial	compartments	to	baseline	values.		
3D	PET	data	were	acquired	in	a	single	list-mode	file	and	re-binned	into	short	
frames	 during	 the	 peak	 influx	 and	 washout	 phases	 (60	 x	 3	 seconds)	 and	 longer	
frames	towards	the	end	of	the	washout	phase	(12	x	15	seconds).	PET	image	frames	
were	reconstructed	using	the	standard	manufacturer-issued	filtered	back-projection	
(FBP)	algorithm	available	on	the	scanner	(344	x	344	matrix,	Gaussian	smoothing	filter	
of	 4	 mm.	 	 Resulting	 PET	 voxel	 sizes	 were	 2.086	 mm	 x	 2.086	 mm	 x	 2.031	 mm.	
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Attenuation	correction	of	PET	data	was	provided	by	the	standard	dual-point	VIBE	T1-
weighted	 Dixon	 sequence	 available	 on	 the	 mMR	 scanner	 front	 end	 (23).	 Total	
attenuation	of	 the	phantom	 is	 low	as	 there	 is	no	attenuating	material	 surrounding	
the	phantom.		
A	mean	 injected	 activity	 of	 207.8±9	MBq	was	 injected	 in	 order	 to	 exclude	
potential	confounding	dead-time	effects	in	the	PET	detectors	which	has	been	shown	
to	occur	in	clinical	situations	(24,	25).	After	preloading	of	[18F]F-	into	the	tubing,	the	
main	bolus	of	GBCA	(Gadovist®,	Bayer	HealthCare,	Berlin,	Germany)	and	[18F]F-	were	
injected	 simultaneously	 via	 a	 contrast	 injection	 system	 (Spectris	 Solaris,	 Bayer	AG,	
Leverkusen,	 Germany)	 through	 the	 vena	 cava	 tubing	 of	 the	 phantom	 (Fig.	 1).	
Simultaneous	dynamic	PET-MR	imaging	was	performed	for	a	total	of	300	seconds.	A	
single	 simultaneous	 PET-MR	 acquisition	was	 performed	 at	 each	PT	 step,	 and	 each	
step	was	repeated	for	an	estimate	of	repeatability	of	the	phantom.	After	each	scan,	
water	 was	 pumped	 through	 the	 myocardial	 compartments	 of	 the	 phantom	 for	 a	
minimum	 of	 60	 seconds	 between	 experiments	 to	 ensure	 a	 complete	 washout	 of	
GBCA	and	radiotracer	before	the	next	scan.		
	
Image	Analysis		
Dynamic	 PET	 images	 were	 analyzed	 in	 PMOD	 v	 3.7	 (PMOD	 Technologies,	
Zurich,	 Switzerland)	 to	 produce	 time-activity	 curves	 (TACs).	 2D	 MR	 images	 were	
analyzed	in	OsiriX	(OsiriX	64-bit,	version	8.0.2,	Pixmeo	SARL,	Geneva,	Switzerland)	to	
produce	 time-intensity	 curves	 (TICs).	 A	 region	 of	 interest	 (ROI)	 of	 1.6	 cm	 (tubing	
diameter)	was	 placed	 over	 the	 aorta	 of	 the	 phantom,	 and	 ROIs	 of	 4	 cm	 diameter	
were	 placed	 over	 the	 left	 and	 right	 myocardial	 sections,	 carefully	 including	 the	
complete	 section	 of	 the	 vessel	 and	 tissue	 compartment	 in	 the	 segmentation.	
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Positioning	of	ROIs	on	 the	PET	 image	plane	 corresponding	 to	 the	MR	 image	plane	
was	determined	 from	 fusion	of	 the	dynamic	3D	PET	and	2D	 summed	dynamic	MR	
images	using	PMOD.	ROIs	were	placed	on	PET	images	over	the	same	spatial	extent	
as	 the	MR	 ROIs.	 The	 PET	 volumes	 of	 interest	 (VOIs)	 were	 6.093	mm	 thick	 (3	 PET	
slices)	in	the	axial-dimension	in	order	to	match	the	slice	thickness	of	the	MR	data	(6	
mm).	All	PET	data	were	decay-corrected	to	the	scan	start	time.	We	thus	produced	a	
set	of	TACs	and	TICs	for	the	aorta	and	myocardial	compartments	over	the	range	of	
PT.		
	
MR	perfusion	calculation	
In-house	 software	was	 used	 for	 perfusion	 quantification	 (Labview	 2014	 for	
Mac,	 National	 Instruments,	 Austin,	 USA).	 A	 model-independent	 deconvolution	
approach	 was	 used	 to	 calculate	 the	 tissue	 impulse	 response	 function,	 providing	
results	 in	 units	 of	 1/second	 (26)	 and	 was	 not	 scaled	 to	 be	 in	 units	 of	 ml/g/min.	
Briefly,	 relative	 perfusion	 can	 be	 calculated	 based	 on	 the	 central	 volume	principle	
using	 a	 signal	 deconvolution	 method	 (27).	 The	 TIC	 for	 the	 myocardial	 uptake	
function,	M(t),	 can	be	calculated	from	the	TIC	 for	 the	arterial	 input	 function,	Cin(t),	
convolved	with	the	tissue	impulse	response	function	h(t):	𝑀 𝑡 = 𝐶!" 𝑡 − 𝜏 ∙ ℎ(𝑡)𝑑𝑡 = 𝐶!" 𝜏 − 𝐶!"#(𝜏) 𝑑𝜏!!!! 		 	 (1)	
in	which	Cout(t)	denotes	the	contrast	concentrations	in	the	venous	out-perfusion.	We	
performed	this	calculation	using	the	pre-bolus	curve,	Cin(t),	as	an	 input	function,	 in	
order	to	minimize	the	effect	of	signal	saturation	by	the	main	bolus	of	higher	GBCA	
concentration,	an	effect	which	has	been	noted	in	previous	work	in	patients	and	with	
this	 phantom	 at	 high	 GBCA	 dosages	 (19,	 22).	 In	 the	 range	 of	 physiological	
concentration	used	in	the	pre-bolus	injection,	MR	signal	intensity	is	proportional	to	
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GBCA	concentration.	The	tissue	impulse	response	function	h(t)	has	the	shape	of	an	
exponential	decay,	and	MR	relative	perfusion	measurements	were	calculated	 from	
the	 h(t))	 when	 h(t=0),	 i.e.	 at	 the	 peak	 value	 of	 the	 exponential	 decay.	 The	 delay	
between	 the	 arterial	 input	 TIC	 and	 the	 myocardial	 TIC	 was	 accounted	 for	 in	 the	
model	(28).		
	
PET	perfusion	calculation	
PET	data	was	modeled	using	a	one-tissue	compartment	model	characterized	
by	 a	 one	 blood	 compartment,	 one	 tissue	 compartment	 and	 two	 rate	 constants	K1	
(uptake	 rate	 constant	 in	 units	 of	 ml/g/min)	 and	 k2	 (clearance	 rate	 from	 tissue	 to	
blood	constant	in	units	of	min-1).	For	this	phantom	study,	using	[18F]F-	we	assume	an	
extraction	fraction	of	1.0	due	to	the	lack	of	any	metabolic	processes,	and	thus	the	K1	
constant	 is	 entirely	 representative	 of	 perfusion.	 In	 order	 to	 eliminate	 any	
prospective	 bias,	 PET	 and	MR	 data	were	 analyzed	 independently	 by	 two	 different	
authors	blinded	to	the	true	myocardial	perfusion	rates,	PT	(PET	analysis	by	JOD,	MR	
analysis	by	AC).		
The	terms	‘flow’	and	‘perfusion’	have	been	used	interchangeably	in	both	PET	
and	MR	literature.	Owing	to	the	fact	that	rates	of	liquid	through	our	phantom	were	
calibrated	 in	 terms	 of	 ml/g/min	 	 (i.e.	 units	 of	 perfusion)	 and	 K1	 values	 from	 PET	
kinetic	 modeling	 were	 in	 the	 same	 units,	 we	 opt	 to	 keep	 consistency	 with	
terminology	and	use	the	term	‘perfusion’	rather	than	‘flow’	(i.e.	units	of	ml/min).	
	
	
Results	
	
Simultaneous	imaging	
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As	 the	 PET	 acquisition	 is	 fully	 3D	 (25.8	 cm	 field	 of	 view),	 all	 myocardial	
chambers	can	be	visualized	simultaneously.	Figure	2	illustrates	the	rapid	passage	of	
radiotracer	from	the	right	atrium	to	ventricle,	through	the	pulmonary	circulation	and	
into	the	left	atrium	and	ventricle	and	exiting	through	the	aorta.		Figure	3	displays	a	
fused	transaxial	 image	of	the	single	MR	slice	with	the	corresponding	merged	3	PET	
slices	 covering	 the	 same	 axial	 extent.	 The	 expected	 GBCA	 and	 PET	 radiotracer	
distribution	 through	 the	phantom	can	be	 seen	at	 increasing	 time	points	of	 the	2D	
MR	imaging	sequence	and	fused	PET-MR	images	detailing	the	first	pass	dynamics	of	
the	phantom.	The	 inset	 image	of	Figure	3	 shows	 the	passage	of	MR	contrast	only,	
which	temporally	matches	the	distribution	of	PET	radiotracer.		
Image	 processing	 of	 the	 ROI/VOIs	 to	 produce	 TACs	 and	 TICs	 allows	
comparison	of	resulting	mean	PET	kBq/ml	to	MR	signal	intensity	during	transit	of	the	
GBCA	 and	 radiotracer,	 as	 shown	 in	 Figure	 4.	 As	 the	 repeat	 injection	 of	 [18F]F-	 and	
GBCA	was	performed	using	the	same	timings	and	methodology	as	the	first	test,	the	
time	traces	produced	by	both	PET	and	MR	data	were	similar.	Although	not	shown	in	
Figure	4	for	clarity,	for	a	single	PT	of	4	ml/g/min,	one	standard	deviation	of	the	mean	
PET	activity	concentration	from	the	VOI	varied	over	time	from	±2	to	±24%,	while	that	
of	the	MR	mean	ROI	signal	intensity	varied	over	time	from	±13%	to	±29%.	Standard	
deviations	were	similar	 for	other	values	of	PT.	 Figure	5	 shows	a	comparison	of	 the	
input	 functions	 from	 both	 imaging	 methodologies	 normalised	 by	 their	 respective	
maximum	 signal	 intensities,	 firstly	 between	 the	main	MR	bolus	 peak	 of	GBCA	 and	
the	radiotracer	(A),	secondly	between	the	MR	prebolus	peak	(which	was	used	for	the	
MR	perfusion	analysis)	and	a	 time-shifted	PET	TAC	overlaid	 to	provide	comparison	
(B),	 and	 finally	 a	 normalized	 comparison	 of	 the	 functions	 obtained	 from	 the	
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myocardial	 chamber	 (C).	 From	 these	 traces,	 it	 can	 be	 observed	 that	 the	 input	
functions	for	both	PET	and	MR	models	show	similar	characteristics.	
	
	
Perfusion	calculations	
	
PET	 datasets	 were	 used	 to	 calculate	 perfusion	 (ml/g/min)	 via	 K1,	 and	 MR	
datasets	 to	 calculate	 relative	 perfusion	 values	 via	 h(t=0)	 as	 described	 above.	
Resulting	K1	and	h(t=0)	and	are	shown	in	Table	1.	Figure	6	shows	three	plots	detailing	
the	relationship	between	K1	and	PT,	h(t=0)	and	PT	and	also	h(t=0)	and	K1.	The	results	
show	that	K1	is	linearly	related	to	PT	(R2=0.99),	and	that	h(t=0)	is	also	linearly	related	
to	both	PT	and	K1	(R2	values	of	0.99	in	both	cases).		
	
	
Discussion	
	
We	 performed	 PET-MR	 tests	 using	 a	 specialized	 cardiac	 phantom	 allowing	
assessment	 of	 myocardial	 perfusion	 measurements	 with	 both	 imaging	
methodologies	 from	 simultaneously	 acquired	data.	 Both	 PET	 and	MR	are	 accurate	
tools	for	the	assessment	of	myocardial	 ischaemia,	however	there	are	drawbacks	to	
each	technique.	For	example	 in	MR,	derivation	of	 fully	quantitative	perfusion	units	
remain	 a	 complex	 process	 due	 to	 the	 relationship	 between	 signal	 intensity	 and	
gadolinium	contrast	and	dependence	on	acquisition	sequence	(3),	Also	2D	imaging	is	
favoured	 due	 to	 dynamic	 imaging	 meaning	 that	 perfusion	 calculations	 cannot	 be	
representative	of	the	entire	volume.	 In	PET,	the	cost	of	the	perfusion	exam	can	be	
prohibitive	 and	 the	 procedure	 is	 based	 on	 access	 to	 short-lived	 radiotracers	 thus	
requiring	 access	 to	 a	 cyclotron.	 There	 is	 also	 a	 not	 insignificant	 radiation	 dose	
associated	 with	 the	 radiotracer.	 Recent	 work	 has	 investigated	 the	 complimentary	
information	generated	by	simultaneous	late	gadolinium	enhancement	and	18F-FDG	
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imaging	(29).	Although	the	principles	of	 image	formation	between	MR	and	PET	are	
based	entirely	on	different	physical	principles,	we	have	shown	that	similar	TACs	and	
TICs	from	the	arterial	and	myocardial	compartments	can	be	obtained	from	a	single	
short	 acquisition.	 Furthermore,	 it	 has	 been	 possible	 to	 show	 that	 the	 results	
obtained	 with	 the	 employed	MR	 and	 PET	models	 are	 linearly	 related	 to	 the	 true	
myocardial	perfusion	rate,	PT.		
The	phantom	is	physiologically	relevant	and	as	such	is	able	to	explore	some	
relevant	 aspects	of	 perfusion	dynamics	of	 the	human	heart.	 Figure	2	 and	 Figure	3	
demonstrate	the	distribution	of	both	GBCA	and	radiotracer	through	the	right	side	of	
the	 cardiac	 chambers	 followed	 by	 the	 left,	with	 perfusion	 through	 the	myocardial	
compartments	 following	 shortly	 after.	 Simultaneous	 traces	 of	 PET	 activity	
concentration	 and	 MR	 signal	 intensity	 in	 Figure	 4	 demonstrate	 the	 transit	 of	
radiotracer	and	GBCA	through	the	phantom,	showing	that	true	simultaneity	of	PET	
and	MR	signals	can	be	achieved	in	this	phantom.	Our	data	also	indicate	that	when	a	
dual	bolus	approach	 is	used	 in	MR,	 linear	perfusion	estimates	to	those	obtained	 in	
PET	can	be	achieved.	
In	this	study,	we	adopted	a	dual-bolus	injection	scheme	previously	described	
and	validated	by	our	group	(22,	30).	The	results	of	this	study	demonstrate	that	this	
approach	 results	 in	MR	 input	 functions	which	are	very	 similar	 in	 shape	and	 transit	
time	 to	 the	 reference	 standard	 PET	 input	 functions	 (Figure	 5).	 The	 myocardial	
compartment	TAC	and	TIC	closely	match	 in	 terms	of	wash-in,	however	 the	MR	TIC	
can	be	observed	to	have	a	longer	transit	time	than	the	radiotracer	(Figure	5,	part	C).	
We	propose	 that	 this	may	be	due	 to	 the	higher	 particle	mass	 and	 viscosity	 of	 the	
GBCA	than	the	radiotracer.		
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One	of	the	main	benefits	of	the	phantom	model	is	its	reproducibility.	Figure	4	
demonstrates	that	repeat	acquisitions	at	the	same	PT	give	similar	TAC	and	TIC.		Upon	
calculation	 of	 perfusion	 via	 PET	 (Table	 1),	 K1	 values	 when	 performed	 with	
independent	repeat	acquisitions	produce	values	in	the	range	of	1.2%	to	7.5%	of	each	
other.	A	similar	repeatability	 is	shown	in	MR	data	with	a	repeatability	of	0.6%-13%	
for	h(t=0).	PET	measurements	at	PT	=	1	ml/g/min	showed	an	overestimation	of	PT	by	
16%,	however	the	PT	 rates	of	2,	3,	4	and	5	ml/g/min	were	accurate	to	K1	values	to	
within	a	maximum	of	2.65%,	 indicating	good	precision	for	repeated	measurements	
and	also	a	 good	accuracy	 to	PT	 values	above	1	ml/g/min.	 	 Inaccuracies	 in	 the	 true	
measurement	of	PT	=	1	ml/g/min	due	to	physical	accuracy	of	the	roller	pumps	may	
account	for	the	larger	differences	at	this	value	of	PT,	and	will	be	investigated	in	the	
next	 generation	 of	 the	 phantom	 currently	 under	 development.	 Although	 h(t=0)	
values	represent	relative	perfusion	measurement	and	were	not	scaled	to	represent	
absolute	perfusion	units,	 their	 relationship	 to	PT	 and	K1	 can	be	 clearly	observed	 in	
Figure	6,	whereby	a	linear	relationship	was	found	between	h(t=0)	and	K1,	as	well	as	
h(t=0)	 and	 PT.	 Another	 potential	 advantage	 of	 the	 approach	 is	 the	 possibility	 to	
address	differences	 in	 the	way	 images	are	acquired	and	modality-specific	artifacts,	
such	as	saturation	effects	in	MR	or	attenuation	correction	in	PET.	
Total	 analysis	 time	 of	 each	 series	 of	 PET	 images	 was	 approximately	 30	
minutes,	 and	 MR	 images	 were	 approximately	 5-10	 minutes.	 Owing	 to	 the	
geometrical	differences	between	phantom	and	patient	images,	semi-automated	PET	
analysis	 software	 could	not	be	used.	 Furthermore,	PET	 images	were	 rebinned	 into	
short	frames	of	3	seconds	because	of	the	rapid	transit	of	the	radiotracer	in	water.	In	
clinical	image	we	expect	a	lower	amount	of	data	and	frames	to	analyse.		
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	 Attenuation	 correction	 is	 a	major	 issue	 in	 clinical	 PET-MR	 imaging	 and	 the	
focus	of	much	research	(31).	 In	this	work,	we	utilised	GBCA	for	the	bolus	 injection,	
and	in	clinical	studies	the	concentration	used	would	be	far	higher.	Previous	work	by	
our	 group	 has	 shown	 that	 despite	 large	 concentrations	 of	 GBCA	 up	 to	 65	 mM	
(presenting	the	scenario	of	GBCA	bolus	in	the	left	ventricle	simultaneously	with	the	
PET	radiotracer),	the	effect	of	attenuation	of	gamma	photons	by	GBCA	on	quantified	
activity	 concentration	 (kBq/ml)	 in	 the	 final	 reconstructed	 images	 is	 less	 than	 5%	
when	compared	to	no	GBCA	present	(32).		
We	 believe	 that	 by	 providing	 a	 standardized	 setup	 and	 known	 perfusion	
rates,	 results,	 claims	 and	 hypotheses	 from	 clinical	 studies	 can	 be	 further	
investigated.	 For	 example,	 in	 a	 recent	 study	 by	 our	 group,	 MFR	 of	 41	 patients	
calculated	from	independent	CMR	and	PET	scans	have	been	shown	to	correlate	well,	
however	 absolute	 CMR	 perfusion	 at	 stress	 and	 rest	 correlated	 weakly	 and	 were	
positively	 biased	 compared	 to	 their	 PET	 counterparts	 (9).	 This	 may	 indicate	 that	
errors	in	quantification	have	a	similar	effect	on	stress	and	rest	perfusion	MBF	values	
but	 are	 cancelled	 by	 calculation	 of	 the	MFR.	 Future	 experiments	 could	 verify	 this	
finding	 by	 the	 exclusion	 of	 physiological	 variation.	 The	 phantom	 also	 allows	
comparison	of	kinetic	models	given	the	known	ground	truth	of	perfusion	rates,	and	
the	potential	for	development	of	new	hybrid	kinetic	models	employing	both	PET	and	
MR	data.		
Knowledge	 of	 the	 relationship	 between	 PT,	 K1	 and	 h(t=0)	 may	 allow	 the	
creation	of	a	modality-specific	calibration	curves.	Particularly	in	the	case	of	perfusion	
MR,	 this	 could	 allow	 converting	 the	 results	 of	 the	 deconvolution	 operation	 from	
seconds-1	 to	 ml/g/min	 of	 perfusion.	 This	 approach	 could	 prove	 of	 value	 as	 a	
substitute	 for	 current	 approaches	 based	 on	 constraining	 the	 deconvolution	
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operation	 (28,	 33).	 This	 may	 lead	 to	 an	 improvement	 in	 the	 correlation	 between	
absolute	MBF	values	measured	with	MR	and	PET,	which	was	shown	to	be	suboptimal	
in	comparison	with	MPR	values	in	previous	studies(9).	
	
Limitations	
The	use	of	the	phantom	in	this	work	for	simultaneous	PET-MR	acquisitions	as	
a	surrogate	for	clinical	acquisitions	presents	some	fundamental	 limitations.	Despite	
the	 fact	 that	 the	 TIC	 and	 TAC	 curves	 are	 similar	 in	 appearance	 for	 this	 simplified	
phantom	study,	it	may	not	be	the	case	for	clinical	studies	in	a	human	cohort	due	to	
the	mechanism	 of	 transport	 of	 radiotracer	 (intracellular)	 and	GBCA	 (extracellular).	
Therefore	 the	 phantom	 study	 serves	 to	 provide	 preliminary	 investigation	 into	 the	
standardized	 comparison	 between	 PET	 and	 MR	 perfusion	 values	 in	 a	 controlled	
simulation.	The	phantom	model	used	in	our	experiments	is	not	able	to	capture	the	
broad	 range	 of	 body	 structures	 and	 physiological	 states	 that	may	 be	 present	 in	 a	
clinical	 setting	 and	 as	 such	 represents	 an	 oversimplification	 of	 the	 cardiovascular	
system	 which	 cannot	 detail	 true	 myocardial	 diffusion	 or	 radiotracer	 uptake.	
Furthermore,	 despite	 a	 good	 correlation	 between	 PET	 and	 MR	 perfusion,	 there	
remain	fundamental	differences	between	the	calculation	methodology	between	the	
MR	model-independent	deconvolution	approach	(leading	to	a	parameter	related	to	
perfusion)	and	perfusion	as	calculated	from	a	single	compartment	PET	model.	As	is	
the	mechanism	with	 PET	 radiotracers,	 no	 separate	 tissue	 compartment	 exists,	 for	
example	 one	 with	 well-defined	 mechanical	 properties	 such	 as	 a	 membrane.	
Therefore	 true	 intracellular	 uptake	 cannot	 be	 simulated,	 only	 allowing	 non-
circulating	extravascular	transfer	of	tracer.	Strategies	would	be	required	in	order	to	
simulate	the	kinetics	of	perfusion	tracers	that	undergo	metabolic	processes	such	as	
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[13N]NH3	 or	 [18F]flurpiridaz.	 Efforts	 should	 be	 made	 to	 create	 myocardial	
compartments	within	the	phantom,	which	would	allow	a	more	accurate	approach	to	
kinetic	modeling.	Furthermore,	we	performed	only	1	repeat	acquisition	of	each	PT	in	
this	feasibility	study,	further	repeat	measurements	would	allow	the	calculation	of	a	
repeatability	coefficient	for	both	the	PET	and	MR	datasets.	
The	 current	 phantom	 model	 setup	 is	 unable	 to	 reproduce	 the	 multiple	
sources	of	image	artifacts	in	PET-MR	such	as	the	effects	of	motion	due	to	respiratory	
or	 cardiac	 contraction.	 Thus	 the	 phantom	 allows	 an	 environment	 free	 from	 these	
potentially	 confounding	 effects	 focusing	 only	 on	 the	 assessment	 of	 the	 perfusion	
dynamics	 within	 the	 cardiac	 compartments.	 However,	 translation	 of	 calibrations	
from	 the	 phantom	 to	 the	 clinical	 setting	 should	 be	 treated	 with	 caution.	
Confounding	factors	from	clinical	data	may	include	the	use	of	respiratory	correction	
via	importing	an	average	cine	CT	or	using	MR-based	navigators(34)	or	employing	MR	
motion-field	 based	 cardiac	motion	 correction	 employed	 in	 PET	 reconstruction(35).	
Efforts	 to	 apply	 these	 techniques	 specifically	 to	 quantitative	 dynamic	 PET-MR	
cardiology	 are	 in	 their	 infancy,	 although	 some	 techniques	 are	 currently	 under	
development	for	static	imaging	(36,	37).		
	
Conclusion	
We	 have	 performed	 a	 feasibility	 study	 of	 the	 first	 simultaneous	 PET-MR	
acquisitions	 from	 a	 dynamic	 cardiac	 perfusion	 phantom,	 showing	 similar	 first-pass	
dynamics	of	both	the	PET	and	MR	contrast	agents.	We	have	described	the	resulting	
simultaneous	 traces,	 showed	 initial	 repeatability	 of	 the	 phantom	 studies	 and	 also	
demonstrated	 a	 correlation	 between	 perfusion	 quantification	 of	 the	 PET	 time-
activity	 traces	 using	 a	 kinetic	model,	 relative	MR	 perfusion	 using	 a	 deconvolution	
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model	 and	 the	 true	 manually	 set	 myocardial	 perfusion	 rate.	 The	 phantom	 shows	
potential	 for	 improving	 standardisation	 of	 perfusion	 measurements,	 analysis	
routines,	 development	 of	 imaging	 protocols	 and	 potential	 calibration	 of	 MR	
perfusion	 values.	 We	 have	 also	 described	 the	 major	 limitations	 of	 the	 system,	
detailing	 how	 these	 phantom	 studies	 are	 an	 important	 stepping	 stone	 allowing	
investigation	of	sequence	development/comparison	and	kinetic	model	development	
in	both	PET	and	MR	modalities.		
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FIGURE	CAPTIONS	
	
Fig.	1	Basic	schematic	representation	of	the	phantom	showing	the	control	unit	outside	the	
scan	 room	 and	 the	 phantom	 components	 inside	 the	 PET-MR	 scanner.	 VC	 =	 vena	 cava,	
PA/PV-pulmonary	 artery/vein,	 RA/LA=right/left	 atrium,	 RV/LV-right/left	 ventricle.	 Image	
modified	from	Chiribiri	et	al	(19).	
	
	
Fig.	2	Single	coronal	PET	slice	from	the	3D	phantom	acquisition	at	a	cardiac	output	rate	of	3	
L/min,	 showing	 an	 example	 of	 radiotracer	 distribution	 in	 the	 myocardial	 chambers	 at	
increasing	 post-injection	 time	 points.	 	 	 All	 images	 are	 shown	 at	 the	 same	windowing	 and	
level.	RA/LA=right/left	atrium,	RV/LV-right/left	ventricle.	
	
Fig.	 3	 Example	 fused	 PET-MR	 images	 showing	 dynamics	 of	 GBCA	 and	 radiotracer	 transfer	
through	the	phantom.	(A)	–	bolus	in	the	VC	(t=0	s).	(B)	–	outperfusion	from	the	RV	through	
the	PA	(t=3	s),	(C)	–	coronary	circulation	to	the	PV	(t=5	s)	and	the	aorta	(AO).	 Inset	 images	
show	the	time	distribution	of	GBCA	only.		
	
	
Fig.	 4	 Comparison	 of	mean	 activity	 concentration	 (kBq/ml)	 time	 activity	 curves	 (TAC)	 and	
mean	MR	signal	(AU)	time	intensity	curves	(TIC)	acquired	from	the	phantom	VOIs	(PET-top)	
and	ROIs	(MR-bottom).	Data	are	presented	for	simultaneous	PET	and	MR	acquisitions	for	a	
myocardial	perfusion	rate,	PT	=	4	ml/g/min	and	cardiac	output	of	3	L/min.	Repeat	scan	data	
using	 ROI	 and	 VOI	 in	 the	 same	 positions	 are	 also	 plotted	 and	 show	 a	 high	 level	 of	
repeatability.	Error	bars	are	omitted	in	order	to	improve	visual	clarity	of	overlapping	traces.	
	
Fig.	 5	 Comparison	 of	 normalized	 (respective	maximum	 signal	 intensity)	 AIFs	 derived	 from	
both	 PET	 and	MR	 signal	 traces	 at	 a	myocardial	 perfusion	 rate	 of	 4	ml/g/min	 and	 cardiac	
output	of	3	l/min.	Image	(A)	represents	the	input	functions	from	the	main	MR	bolus	and	PET	
bolus,	 showing	 a	 longer	 washout	 of	 GBCA	 than	 radiotracer	 in	 the	 main	 bolus.	 Image	 (B)	
details	 the	 MR	 prebolus	 with	 the	 same	 PET	 bolus	 as	 (A)	 but	 time-shifted	 to	 provide	
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comparison.	 Image	 (C)	 details	 the	 simultaneous	 curves	 from	 the	myocardial	 compartment	
showing	a	clear	difference	in	transit	time,	potentially	due	to	higher	mass	and	viscosity	of	the	
GBCA.		
	
Fig.	 6	 Top	 -	 Resulting	 K1	 values	 from	 a	 single	 compartment	 model	 for	 PET	 data	
plotted	 against	 PT.	 Middle	 –	 MR	 values	 of	 h(t=0)	 from	 model-independent	
deconvolution	for	MR	images	plotted	against	the	range	of	PT.	Bottom	-	MR	values	of	
h(t=0)	plotted	against	the	range	of	K1	from	PET	kinetic	modeling.		
	
	
